Jeffrey Peters
Distinguished Professor of Molecular Toxicology and Carcinogenesis

-
312 Huck Life Sciences
University Park, PA 16802 - jmp21@psu.edu
- 814-863-1387
Research Summary
Roles of peroxisome proliferator-activated receptors (PPARs) in the regulation of homeostasis, toxicology, and carcinogenesis.
Huck Affiliations
Links
Publication Tags
Peroxisome Proliferator Activated Receptors Neoplasms Tumors Liver Carcinogenesis Pharmacological Metabolism Cytoplasmic And Nuclear Receptors Fatty Acid Rodentia Ligand Weight Macrophage Colony Stimulating Factor Peroxisome Proliferator Activated Receptor Agonist Dose Ppar Alpha Fatty Acid Synthases Industrial Substance Perfluorooctane Sulfonic Acid Ppar Delta Ligands Oxidative Stress Cells Chemical Activation Therapeutics ChemopreventionMost Recent Papers
Targeting peroxisome proliferator-activated receptor-β/δ (pparβ/δ) for the treatment or prevention of alcoholic liver disease
Takayuki Koga, Jeffrey M. Peters, 2021, Biological and Pharmaceutical Bulletin on p. 1598-1606
Species Differences between Mouse and Human PPARα in Modulating the Hepatocarcinogenic Effects of Perinatal Exposure to a High-Affinity Human PPARα Agonist in Mice
Jennifer E. Foreman, Takayuki Koga, Oksana Kosyk, Boo Hyon Kang, Xiaoyang Zhu, Samuel M. Cohen, Laura J. Billy, Arun K. Sharma, Shantu Amin, Frank J. Gonzalez, Ivan Rusyn, Jeffrey M. Peters, 2021, Toxicological Sciences on p. 81-92
Diminished Hepatocarcinogenesis by a Potent, High-Affinity Human PPARα Agonist in PPARA-Humanized Mice
Jennifer E. Foreman, Takayuki Koga, Oksana Kosyk, Boo Hyon Kang, Xiaoyang Zhu, Samuel M. Cohen, Laura J. Billy, Arun K. Sharma, Shantu Amin, Frank J. Gonzalez, Ivan Rusyn, Jeffrey M. Peters, 2021, Toxicological Sciences on p. 70-80
Current Challenges and Recent Developments in Mass Spectrometry-Based Metabolomics
Stephanie L. Collins, Imhoi Koo, Jeffrey M. Peters, Philip B. Smith, Andrew D. Patterson, 2021, Annual Review of Analytical Chemistry on p. 467-487
Perfluorooctane sulfonate alters gut microbiota-host metabolic homeostasis in mice
Limin Zhang, Bipin Rimal, Robert G. Nichols, Yuan Tian, Philip B. Smith, Emmanuel Hatzakis, Shu Ching Chang, John L. Butenhoff, Jeffrey M. Peters, Andrew D. Patterson, 2020, Toxicology
Moving forward with ToxSci
Jeffrey M. Peters, 2020, Toxicological Sciences on p. 227-228
Change is Good
Jeffrey M. Peters, 2020, Toxicological Sciences on p. 1-2
Unraveling the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) expression in colon carcinogenesis
Jeffrey Maurice Peters, Vonn Walter, Andrew David Patterson, Frank J. Gonzalez, 2019, npj Precision Oncology
Regulatory mechanisms mediated by peroxisome proliferator-activated receptor-β/δ in skin cancer
Jeffrey M. Peters, Dae J. Kim, Moses T. Bility, Michael G. Borland, Bokai Zhu, Frank J. Gonzalez, 2019, Molecular Carcinogenesis on p. 1612-1622
Continuing a Legacy
Jeffrey M. Peters, 2019, Toxicological Sciences on p. 1-2
Most-Cited Papers
The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention
Jeffrey M. Peters, Yatrik M. Shah, Frank J. Gonzalez, 2012, Nature Reviews Cancer on p. 181-195
Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARα) as a case study
J. Christopher Corton, Michael L. Cunningham, B. Timothy Hummer, Christopher Lau, Bette Meek, Jeffrey M. Peters, James A. Popp, Lorenz Rhomberg, Jennifer Seed, James E. Klaunig, 2014, Critical Reviews in Toxicology on p. 1-49
Lipid metabolism and lipophagy in cancer
Meenu Maan, Jeffrey M. Peters, Mainak Dutta, Andrew D. Patterson, 2018, Biochemical and Biophysical Research Communications on p. 582-589
The PPARα-dependent rodent liver tumor response is not relevant to humans
J. Christopher Corton, Jeffrey M. Peters, James E. Klaunig, 2018, Archiv fur Toxikologie on p. 83-119
Establishing the Role of PPARβ/δ in Carcinogenesis
Jeffrey M. Peters, Frank J. Gonzalez, Rolf Müller, 2015, Trends in Endocrinology and Metabolism on p. 595-607
M-CSF from cancer cells induces fatty acid synthase and PPARβ/δ activation in tumor myeloid cells, leading to tumor progression
Jonghanne Park, Sang Eun Lee, Jin Hur, Eun Byeol Hong, Jae Il Choi, Ji Min Yang, Ju Young Kim, Young Chan Kim, Hyun Jai Cho, Jeffrey M. Peters, Seung Bum Ryoo, Young Tae Kim, Hyo Soo Kim, 2015, Cell Reports on p. 1614-1625
Activation of peroxisome proliferator-activated receptor-β/δ (PPAR-β/δ) inhibits human breast cancer cell line tumorigenicity.
Pei Li Yao, Jose L. Morales, Bokai Zhu, Boo Hyon Kang, Frank J. Gonzalez, Jeffrey M. Peters, 2014, Molecular Cancer Therapeutics on p. 1008-1017
Aryl hydrocarbon receptor antagonism attenuates growth factor expression, proliferation, and migration in fibroblast-like synoviocytes from patients with rheumatoid arthritis
Tejas S. Lahoti, Jarod M. Hughes, Ann Kusnadi, Kaarthik John, Bokai Zhu, Iain A. Murray, Krishne Gowda, Jeffrey M. Peters, Shantu G. Amin, Gary H. Perdew, 2014, Journal of Pharmacology and Experimental Therapeutics on p. 236-245
The nuclear receptor peroxisome proliferator-activated receptor-β/ δ (PPARβ/δ) promotes oncogene-induced cellular senescence through repression of endoplasmic reticulum stress
Bokai Zhu, Christina H. Ferry, Lauren K. Markell, Nicholas Blazanin, Adam B. Glick, Frank J. Gonzalez, Jeffrey M. Peters, 2014, Journal of Biological Chemistry on p. 20102-20119
Analysis of the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) cistrome reveals novel co-regulatory role of ATF4
Combiz Khozoie, Michael G. Borland, Bokai Zhu, Songjoon Baek, Sam John, Gordon L. Hager, Yatrik M. Shah, Frank J. Gonzalez, Jeffrey M. Peters, 2012, BMC Genomics